Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Ocaratuzumab (Anti-CD20) For research use only.
Not for use in humans.

Ocaratuzumab (Anti-CD20)

Synonyms: AME 133v, LY 2469298

Ocaratuzumab (anti-CD20) is a Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC). MW: 145.38 kD.

Ocaratuzumab (Anti-CD20)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ocaratuzumab (anti-CD20) is a Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC). MW: 145.38 kD.

Product Details

CAS No. 1169956-08-4
Molecular Weight 145.38
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ocaratuzumab (Anti-CD20) | Ocaratuzumab (Anti-CD20) supplier | purchase Ocaratuzumab (Anti-CD20) | Ocaratuzumab (Anti-CD20) cost | Ocaratuzumab (Anti-CD20) manufacturer | order Ocaratuzumab (Anti-CD20) | Ocaratuzumab (Anti-CD20) distributor